Anlotinib exerts anti‐cancer efficiency on lung cancer stem cells in vitro and in vivo through reducing NF‐κB activity

Journal of Cellular and Molecular Medicine

Lei Du¹  Zhuohong Li¹  Ying Gao¹  Fengming You¹  Yao Wang¹  Li Wang²  Juncai Tian³ 

[1] Department of Oncology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China;Lung Cancer Center, State Key Laboratory of Biotherapy, West China Hospital of Sichuan University, Chengdu, China;Lung Cancer Center, State Key Laboratory of Biotherapy, West China Hospital of Sichuan University, Chengdu, China;Department of Respiratory Medicine, The First People’s Hospital of Ziyang, Ziyang, China;

关键词: anlotinib;    apoptosis;    cancer stem cell;    NF‐κB;   

DOI  :  10.1111/jcmm.16564

来源: Wiley

【 授权许可】

CC BY